Vaccibody Current Valuation vs. Number Of Shares Shorted
| VACCDelisted Stock | USD 2.23 0.04 1.83% |
For Vaccibody profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vaccibody to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vaccibody As utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vaccibody's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vaccibody As over time as well as its relative position and ranking within its peers.
Vaccibody |
Vaccibody As Number Of Shares Shorted vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vaccibody's current stock value. Our valuation model uses many indicators to compare Vaccibody value to that of its competitors to determine the firm's financial worth. Vaccibody As is rated below average in current valuation category among its peers. It is rated below average in number of shares shorted category among its peers . The ratio of Current Valuation to Number Of Shares Shorted for Vaccibody As is about 201.14 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaccibody by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaccibody's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Vaccibody Current Valuation vs. Competition
Vaccibody As is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 10.2 Billion. Vaccibody adds roughly 32.03 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Vaccibody Number Of Shares Shorted vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Vaccibody |
| = | 32.03 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Vaccibody |
| = | 159.22 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Vaccibody Number Of Shares Shorted Comparison
Vaccibody is currently under evaluation in number of shares shorted category among its peers.
Vaccibody Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vaccibody, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vaccibody will eventually generate negative long term returns. The profitability progress is the general direction of Vaccibody's change in net profit over the period of time. It can combine multiple indicators of Vaccibody, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom. Vaccitech Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Vaccibody Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vaccibody. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vaccibody position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vaccibody's important profitability drivers and their relationship over time.
Use Vaccibody in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaccibody position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccibody will appreciate offsetting losses from the drop in the long position's value.Vaccibody Pair Trading
Vaccibody As Pair Trading Analysis
The ability to find closely correlated positions to Vaccibody could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaccibody when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaccibody - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaccibody As to buy it.
The correlation of Vaccibody is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaccibody moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaccibody As moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaccibody can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vaccibody position
In addition to having Vaccibody in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Vaccibody Stock
If you are still planning to invest in Vaccibody As check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccibody's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |